Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPOSTEROUS2: Pre- vs Postoperative Thromboprophylaxis in Pancreatic Surgery
NCT05245877Phase 4Recruiting
- Sponsor
- Helsinki University Hospital
- Start
- Aug 2022
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 4 trial of enoxaparin, tinzaparin, dalteparin in venous thromboembolism (VTE), sponsored by Helsinki University Hospital. Started Aug 2022; status: recruiting.
02
Drugs
enoxaparintinzaparindalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05245877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05245877.